Lin I-Chan, Wang Yuan-Hung, Lin Cheng-Li, Chang Yen-Jung, Lee Shwu-Huey, Wang I-Jong
Department of Ophthalmology, Shuang-Ho Hospital-Taipei Medical University, New Taipei City, Taiwan.
Division of Urology, Department of Surgery, Taipei Medical University- Shuang Ho Hospital, New Taipei City, Taiwan.
Acta Ophthalmol. 2015 Dec;93(8):713-8. doi: 10.1111/aos.12746. Epub 2015 May 19.
To assess the relationship between diabetic polyneuropathy (DPN) and the risk of diabetic retinopathy (DR).
From 1997 to 2010, we identified 5031 newly diagnosed DPN patients and 20 124 controls matched for sex, age, and index year. Cox proportional hazards regression analyses were used to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of DR between the DPN patients and the non-DPN group. The adjusted hazard ratio was calculated and adjusted for age, sex, duration of diabetes and comorbidities of hypertension, cardiovascular disease and diabetic nephropathy.
The incidence rate of DR was 5.87-fold higher in the DPN patients than in the non-DPN group (44.0 vs. 7.22 per 1000 person-years), with an adjusted HR of 5.41(95% CI = 4.92-5.94). The DPN-to-non-DPN DR incidence rate ratio decreased with age (adjusted HR = 6.63 for subgroup younger than 65 years and adjusted HR = 3.91 for subgroup aged 65 years or older). Compared with the non-DPN group, the DPN patients had a 5.63-fold risk of non-proliferative DR (adjusted HR = 5.63, 95% CI = 5.11-6.21) and a 3.67-fold risk of proliferative DR (adjusted HR = 3.67, 95% CI = 2.57-5.23).
The patients with DPN had an increased risk of developing DR and advanced DR compared with the non-DPN group, particularly among the subgroup aged younger than 65 years.
评估糖尿病性多发性神经病变(DPN)与糖尿病视网膜病变(DR)风险之间的关系。
1997年至2010年期间,我们确定了5031例新诊断的DPN患者以及20124例在性别、年龄和索引年份上匹配的对照。采用Cox比例风险回归分析来估计DPN患者与非DPN组之间DR的校正风险比(HR)和95%置信区间(CI)。计算校正风险比,并对年龄、性别、糖尿病病程以及高血压、心血管疾病和糖尿病肾病等合并症进行校正。
DPN患者的DR发病率比非DPN组高5.87倍(每1000人年分别为44.0和7.22),校正HR为5.41(95%CI = 4.92 - 5.94)。DPN与非DPN的DR发病率比随年龄降低(65岁以下亚组的校正HR = 6.63,65岁及以上亚组的校正HR = 3.91)。与非DPN组相比,DPN患者发生非增殖性DR的风险高5.63倍(校正HR = 5.63,95%CI = 5.11 - 6.21),发生增殖性DR的风险高3.67倍(校正HR = 3.67,95%CI = 2.57 - 5.23)。
与非DPN组相比,DPN患者发生DR和晚期DR的风险增加,尤其是在65岁以下的亚组中。